Finance

Lists
Q2 2026 earnings • released • EPS miss -133.33% • Revenue miss -0.16%
See results
INGN:NASDAQ
Inogen Inc
$6.05
-6.78%
(-0.44) 1D
Aug 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INGN...
Open
$5.90
High
$6.26
Low
$5.61
Mkt. cap
163.80M
Avg. vol.
229.37K
Volume
599.11K
52-wk high
$9.13
52-wk low
$5.34
EPS
-$0.92
Beta
1.56
Shares outstanding
27.08M
No. of employees
753
Open
$5.90
High
$6.26
Low
$5.61
Mkt. cap
163.80M
Avg. vol.
229.37K
Volume
599.11K
52-wk high
$9.13
52-wk low
$5.34
EPS
-$0.92
Beta
1.56
Shares outstanding
27.08M
No. of employees
753
News stories
From sources across the web
About Inogen Inc
CEOKevin R. Smith
Employees753
Founded2001
HeadquartersGoleta, California, United States
SectorMedical device
Websiteprovider.inogen.com
Analyst ratings
Based on 2 analysts giving stock ratings to INGN in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for INGN in the last 3 months.
Highest
Current $6.05
$14.00 (+131.40%)
Average
$13.00 (+114.88%)
Lowest
$12.00 (+98.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
B. Riley Securities
Buy
Initiated
$14.00
+131.4%
08/07/2026
Michael Matson
Needham
Buy
Reiterated
$12.00
+98.3%
08/07/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
$12.00
+98.3%
04/07/2026
Anderson Schock
B. Riley Securities
Buy
Reiterated
$14.00
+131.4%
01/21/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.14 / -$0.06
-133.33%miss
Revenue / Est. (USD)
95.08M / 95.23M
-0.16%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
92.39M
81.72M
85.11M
95.08M
Cost of goods sold
51.07M
46.48M
47.25M
51.81M
Cost of revenue
51.07M
46.48M
47.25M
51.81M
Research and development expenses
4.84M
5.32M
5.10M
5.87M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41.81M
39.23M
41.18M
42.50M
Operating expense
46.65M
44.54M
46.28M
48.37M
Total operating expenses
97.72M
91.03M
93.53M
100.18M
Operating income
-5.33M
-9.31M
-8.42M
-5.10M
Other non operating income
606.00K
-520.00K
-42.00K
231.00K
EBT including unusual items
-5.44M
-7.36M
-8.50M
-4.00M
EBT excluding unusual items
-3.66M
-7.36M
-7.58M
-4.00M
Income tax expense
-146.00K
-236.00K
-174.00K
-154.00K
Effective tax rate
2.68%
3.21%
2.05%
3.85%
Other operating expenses
-
-
-
-
Net income
-5.29M
-7.13M
-8.32M
-3.85M
Net profit margin
-5.73%
-8.72%
-9.78%
-4.05%
Earnings per share
-0.02
-0.15
-0.14
-
Interest and investment income
1.07M
1.16M
880.00K
861.00K
Interest expense
-
-
-
-
Net interest expenses
1.07M
1.16M
880.00K
861.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-113.00K
-4.27M
-3.52M
-399.00K
Gain or loss from assets sale
1.04M
572.00K
563.00K
698.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps